(Q40710163)

23 September 2017

Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells (English)

1 reference

23 September 2017

multiple drug resistance

1 reference

Green LJ

1

1 reference

23 September 2017

Marder P

series ordinal

2

1 reference

23 September 2017

Slapak CA

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

23 September 2017

Biochemical Pharmacology

1 reference

23 September 2017

61

1 reference

23 September 2017

11

1 reference

23 September 2017

1393-1399

1 reference

The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Inhibitors of multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Flow cytometric analysis of the multiple drug resistance phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Flow cytometric analysis of P-glycoprotein function using rhodamine 123

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

Multidrug resistance activity in human lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900599-8

10.1016/S0006-2952(01)00599-8

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference